Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2026 ,inter alia, to consider and approve 1. To consider and ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals (formerly Trimurthi Limited) has called a Board Meeting on June 4, 2026. The main item on the agenda is to consider and approve the issuance of securities on a preferential basis, subject to shareholder and regulatory approvals. The Board will also adopt the draft notice for an Extra Ordinary General Meeting (EGM), fix the EGM's date, time, and venue, and appoint a scrutinizer to oversee the e-voting process at the EGM. The company's trading window has been closed from June 1, 2026, until 48 hours after the outcome is made public, restricting insiders from trading in the stock during this period. The company is listed on BSE with scrip code 536565.
Shareholders may see dilution if the preferential allotment goes through, as new securities will be issued to select investors. The stock could see movement around the Board meeting date, especially given the closed trading window signaling potentially price-sensitive news. Approval of the EGM is the next major step before the actual issue price and quantity are finalized.